Differential Expression of COX-1 and COX-2 in the Gastrointestinal Tract of the Rat

The aim of this study was to use immunohistochemistry with morphometry to investigate COX-1 and COX-2 expression in the normal rat gastrointestinal (GI) tract and examine if sites of ulceration previously observed with long-term COX-2 inhibitor administration in mice correlate with differential COX-1/COX-2 expression. COX-2 positive cells were observed predominantly in the apical lamina propria of intestinal villi with fewer cells in the mucosal epithelium. The highest level of COX-2 expression was observed at the ileocaecal junction (ICJ). COX-2 expression was also present in parasympathetic ganglia of the submucosa and muscularis. In the stomach, the highest grade of COX-2 expression was observed in the apical lamina propria of the fundus adjacent to the junctional ridge. In contrast, COX-1 positive cells within the lamina propria were evenly distributed along the GI tract but were present in higher numbers than COX-2 positive cells. The mean level of COX-1 expression at the ICJ was not significantly different from the ileum and caecum. Evidence that the highest level of COX-2 expression in normal rats is located on the ileal side of the ICJ provides the first mechanism to explain spontaneous ulceration and perforation of the distal ileum in COX-2−/− animals.

[1]  K. Westover,et al.  Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs. , 2004, American journal of veterinary research.

[2]  L. Kopelovich,et al.  Cyclooxygenases in the skin: pharmacological and toxicological implications. , 2003, Toxicology and applied pharmacology.

[3]  R. Simpson,et al.  NSAIDs: the Emperor’s new dogma? , 2003, Gut.

[4]  R. Simpson,et al.  COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice. , 2002, Gastroenterology.

[5]  A. Tarnawski,et al.  NSAID inhibition of RGM1 gastric monolayer wound re-epithelialization: comparison of selective Cox-2 versus non-selective Cox inhibitors. , 2002, Life sciences.

[6]  K. Takeuchi,et al.  Up‐regulation of COX‐2 by inhibition of COX‐1 in the rat: a key to NSAID‐induced gastric injury , 2002, Alimentary pharmacology & therapeutics.

[7]  二神 綾子 Wound healing involves induction of cyclooxygenase-2 expression in rat skin , 2002 .

[8]  P. O’Brien,et al.  Rat colorectal tumours treated with a range of non-steroidal anti-inflammatory drugs show altered cyclooxygenase-2 and cyclooxygenase-1 splice variant mRNA expression levels. , 2001, Carcinogenesis.

[9]  H. Roy,et al.  Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non‐steroidal anti‐inflammatory drug nabumetone , 2001, International journal of cancer.

[10]  S. Miyamoto,et al.  Upregulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[11]  R. Lorenz,et al.  Spontaneous and Continuous Cyclooxygenase-2-Dependent Prostaglandin E2 Production by Stromal Cells in the Murine Small Intestine Lamina Propria: Directing the Tone of the Intestinal Immune Response1 , 2001, The Journal of Immunology.

[12]  B. Thjódleifsson,et al.  Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen , 2001, Gut.

[13]  J. Wallace,et al.  NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. , 2000, Gastroenterology.

[14]  I. Bjarnason,et al.  Comparison of the intestinal toxicity of celecoxib, a selective COX-2 inhibitor, and indomethacin in the experimental rat. , 2000, Scandinavian journal of gastroenterology.

[15]  S. Yamashina,et al.  Cyclo‐oxygenase‐2 enhances basic fibroblast growth factor‐induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants , 2000, British journal of pharmacology.

[16]  P. O’Brien,et al.  Cyclooxygenase-1 and an alternatively spliced mRNA in the rat stomach: effects of aging and ulcers. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[17]  G Geisslinger,et al.  Effects of selective and unselective cyclooxygenase inhibitors on prostanoid release from various rat organs. , 2000, The Journal of pharmacology and experimental therapeutics.

[18]  A B West,et al.  Myofibroblasts. II. Intestinal subepithelial myofibroblasts. , 1999, American journal of physiology. Cell physiology.

[19]  C. Hawkey COX-2 inhibitors , 1999, The Lancet.

[20]  C. Bonifer,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1998.0224 Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice , 2022 .

[21]  D. Powell Intestinal subepithelial myofibroblasts , 1999 .

[22]  J. Mazuski,et al.  The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis. , 1999, The Journal of surgical research.

[23]  G. Crosthwaite,et al.  Proton pump inhibitors for Barrett's oesophagus , 2000, Gut.

[24]  K. Schrör,et al.  Constitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa. , 1998, Molecular pharmacology.

[25]  P. Netzer,et al.  Effects of inhibition of prostaglandin endoperoxide synthase‐2 in chronic gastro‐intestinal ulcer models in rats , 1998, British journal of pharmacology.

[26]  K. Seibert,et al.  Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. , 1997, The Journal of clinical investigation.

[27]  Y. Watanabe,et al.  Induction of Cyclooxygenase‐2 in the Brain by Cytokines , 1997, Annals of the New York Academy of Sciences.

[28]  M. Kasuga,et al.  Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. , 1997, Gastroenterology.

[29]  J. Wallace,et al.  Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. , 1996, The Journal of clinical investigation.

[30]  J. Mitchell,et al.  Cyclooxygenase-2: regulation and relevance in inflammation. , 1995, Biochemical pharmacology.

[31]  Hyung-Suk Kim,et al.  Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration , 1995, Cell.

[32]  A. Dhillon,et al.  Intestinal site‐dependent susceptibility to chronic indomethacin in the rat: a morphological and biochemical study , 1995, Alimentary pharmacology & therapeutics.

[33]  J. Otto,et al.  Different Intracellular Locations for Prostaglandin Endoperoxide H Synthase-1 and −2 (*) , 1995, The Journal of Biological Chemistry.

[34]  J. Otto,et al.  The orientation of prostaglandin endoperoxide synthases-1 and -2 in the endoplasmic reticulum. , 1994, The Journal of biological chemistry.

[35]  A. Levi,et al.  Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. , 1987, Gastroenterology.

[36]  R. Tompkins Nonsteroidal anti-inflammatory drugs. , 2019, Minnesota medicine.